TY - JOUR AU - Yobi, Doudou M. AU - Kayiba, Nadine K. AU - Mvumbi, Dieudonné M. AU - Boreux, Raphael AU - Kabututu, Pius Z. AU - Situakibanza, Hippolyte N. T. AU - Umesumbu, Solange E. AU - De Mol, Patrick AU - Speybroeck, Niko AU - Mvumbi, Georges L. AU - Hayette, Marie-Pierre PY - 2021 DA - 2021/03/11 TI - Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019 JO - Malaria Journal SP - 144 VL - 20 IS - 1 AB - The national policy for malaria treatment of the Democratic Republic of Congo recommends two first-line artemisinin-based combinations for the treatment of uncomplicated malaria: artesunate-amodiaquine and artemether-lumefantrine. This study investigated the presence of markers associated with resistance to the current first-line artemisinin-based combination therapy (ACT) in isolates of Plasmodium falciparum from treatment failure patients in the Democratic Republic of Congo. SN - 1475-2875 UR - https://doi.org/10.1186/s12936-021-03636-y DO - 10.1186/s12936-021-03636-y ID - Yobi2021 ER -